RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 123 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $291,000 | -74.0% | 22,306 | -60.9% | 0.00% | -66.7% |
Q2 2021 | $1,118,000 | -82.2% | 57,078 | -80.6% | 0.00% | -81.2% |
Q1 2021 | $6,267,000 | +790.2% | 294,660 | +1144.3% | 0.02% | +700.0% |
Q4 2020 | $704,000 | +49.5% | 23,681 | +8.9% | 0.00% | 0.0% |
Q3 2020 | $471,000 | -51.1% | 21,742 | -48.1% | 0.00% | -33.3% |
Q4 2019 | $963,000 | +280.6% | 41,922 | +264.5% | 0.00% | +200.0% |
Q2 2019 | $253,000 | -34.6% | 11,500 | -18.6% | 0.00% | 0.0% |
Q1 2019 | $387,000 | – | 14,129 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |